TORL BioTherapeutics
Developer of a drug development company designed to focus on antibody-drug conjugates (ADCs) and other biologics. The company leverages target identification and early discovery work before electing t...
Valuation
$0
Share Price
N/A
Total Raised
$454.3M
Last Round
N/A